MEET US AT ISPOR!

Directors (5).jpg

The Vitaccess team is excited to share new findings of its digital studies in Melanoma and rare diseases Charcot-Marie-Tooth and Beta-Thalassemia at ISPOR Europe in Copenhagen, 2-6 November.

We will also present a short- course on Saturday 2 November in the afternoon.

Come and say hello at our poster presentations to discover more about our patient-centric studies and visit our booth C2-025 to have a chat on how we can help you!

Please note: all times are in local time

THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH EUROPEAN CONFERENCE

SHORT COURSE

Saturday, 2 November: 13:00-17:00

Short-course presentation by Dr Mark Larkin, Jon Spinage and Dr Annabel Nixon

  • Digital real-world evidence generation approaches in rare diseases and oncology

 
isporeurope2019_730x90.jpg
e-signature ISPOR 2019 Copenhagen FINAL.png
 

POSTERS

Monday, 4 November: 15:30-18:00

  • PCN265: Targeted review of adverse events associated with treatments for stage 3 and 4 Melanoma

  • PCN188: The cost-effectiveness of supplemental parenteral nutrition in oncology

Wednesday, 6 November: 09:30-14:00

  • PRO37: Healthcare resource use in Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world study

  • PRO93: Demographics and treatment patterns for Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world study

  • PRO116: Understanding the role of real-world evidence in Health Technology Assessment for orphan drugs

  • PRO136: Patient-reported burden of transfusion-dependent Beta-Thalassemia in the USA and UK measured using a digital app

  • PRO138: Productivity losses in people with Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world evidence study

 
 
Coralie Rassinoux